1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Ziarek, J.J.
Peterson, F.C.
Volkman, B.F.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Sci Signal
1937-9145
10
10.1126/scisignal.aah5756
28325822
Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation.
2017
10.2210/pdb2n55/pdb
pdb_00002n55
8146.680
Stromal cell-derived factor 1
L76C, I79C
1
man
polymer
4518.772
C-X-C chemokine receptor type 4
C28A
1
man
polymer
SDF-1, hSDF-1, C-X-C motif chemokine 12, Intercrine reduced in hepatomas, IRH, hIRH, Pre-B cell growth-stimulating factor, PBSF, SDF-1-beta(3-72), SDF-1-alpha(3-67)
CXC-R4, CXCR-4, FB22, Fusin, HM89, LCR1, Leukocyte-derived seven transmembrane domain receptor, LESTR, Lipopolysaccharide-associated protein 3, LAP-3, LPS-associated protein 3, NPYRL, Stromal cell-derived factor 1 receptor, SDF-1 receptor
no
no
GMKPVSLSYRCPCRFFESHVARANVKHLKILNTPNCALQIVARLKNNNRQVCIDPKCKWCQEYLEKALNK
GMKPVSLSYRCPCRFFESHVARANVKHLKILNTPNCALQIVARLKNNNRQVCIDPKCKWCQEYLEKALNK
A
polypeptide(L)
no
no
GSMEGISIYTSDNYTEEMGSGDYDSMKEPAFREENANFNK
GSMEGISIYTSDNYTEEMGSGDYDSMKEPAFREENANFNK
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
sample
CXCL12, SDF1, SDF1A, SDF1B
9606
Homo sapiens
562
Escherichia coli
plasmid
pQE30
human
sample
CXCR4
9606
Homo sapiens
562
Escherichia coli
plasmid
pQE30
database_2
pdbx_database_status
pdbx_nmr_software
struct_ref_seq_dif
repository
Initial release
Database references
Database references
Database references
Data collection
Database references
Other
1
0
2016-04-27
1
1
2016-05-11
1
2
2016-05-25
1
3
2017-05-03
1
4
2023-06-14
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.status_code_nmr_data
_pdbx_nmr_software.name
_struct_ref_seq_dif.details
BMRB
Y
RCSB
2015-07-07
REL
REL
REL
REL
1533
365
486
241
441
57
52
target function
100
20
1
3D 1H-15N NOESY
3D 1H-13C NOESY aliphatic
3D 1H-13C NOESY aromatic
3D 1H-15N NOESY
3D 1H-13C NOESY aliphatic
3D 1H-13C NOESY aromatic
3D F1-13C filtered/F3-13C edited NOESY aliphatic
3D F1-13C filtered/F3-13C edited NOESY aliphatic
2
mM
[U-99% 13C; U-99% 15N]
25
mM
[U-2H]
10
%
[U-99% 2H]
0.02
%
2
mM
1
mM
[U-99% 13C; U-99% 15N]
25
mM
[U-2H]
0.02
%
10
%
[U-99% 2H]
2
mM
0.02
6.8
ambient
298
K
torsion angle dynamics, molecular dynamics
1
lowest energy
2 mM [U-99% 13C; U-99% 15N] protein_1, 25 mM [U-2H] MES, 10 % [U-99% 2H] D2O, 0.02 % sodium azide, 2 mM protein_2, 90% H2O/10% D2O
90% H2O/10% D2O
1 mM [U-99% 13C; U-99% 15N] protein_2, 25 mM [U-2H] MES, 0.02 % sodium azide, 10 % [U-99% 2H] D2O, 2 mM protein_1, 90% H2O/10% D2O
90% H2O/10% D2O
Guntert, Mumenthaler and Wuthrich
structure solution
CYANA
Guntert, Mumenthaler and Wuthrich
refinement
CYANA
Bartels et al.
chemical shift assignment
XEASY
Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
processing
NMRPipe
Bartels, Guntert, Billeter and Wuthrich
chemical shift assignment
GARANT
Bruker Biospin
collection
TopSpin
Schwieters, Kuszewski, Tjandra and Clore
geometry optimization
X-PLOR NIH
Cornilescu, Delaglio and Bax
data analysis
TALOS
refinement
X-PLOR NIH
600
Bruker
DRX
Bruker DRX
GLY
-1
n
1
GLY
-1
A
MET
0
n
2
MET
0
A
LYS
1
n
3
LYS
1
A
PRO
2
n
4
PRO
2
A
VAL
3
n
5
VAL
3
A
SER
4
n
6
SER
4
A
LEU
5
n
7
LEU
5
A
SER
6
n
8
SER
6
A
TYR
7
n
9
TYR
7
A
ARG
8
n
10
ARG
8
A
CYS
9
n
11
CYS
9
A
PRO
10
n
12
PRO
10
A
CYS
11
n
13
CYS
11
A
ARG
12
n
14
ARG
12
A
PHE
13
n
15
PHE
13
A
PHE
14
n
16
PHE
14
A
GLU
15
n
17
GLU
15
A
SER
16
n
18
SER
16
A
HIS
17
n
19
HIS
17
A
VAL
18
n
20
VAL
18
A
ALA
19
n
21
ALA
19
A
ARG
20
n
22
ARG
20
A
ALA
21
n
23
ALA
21
A
ASN
22
n
24
ASN
22
A
VAL
23
n
25
VAL
23
A
LYS
24
n
26
LYS
24
A
HIS
25
n
27
HIS
25
A
LEU
26
n
28
LEU
26
A
LYS
27
n
29
LYS
27
A
ILE
28
n
30
ILE
28
A
LEU
29
n
31
LEU
29
A
ASN
30
n
32
ASN
30
A
THR
31
n
33
THR
31
A
PRO
32
n
34
PRO
32
A
ASN
33
n
35
ASN
33
A
CYS
34
n
36
CYS
34
A
ALA
35
n
37
ALA
35
A
LEU
36
n
38
LEU
36
A
GLN
37
n
39
GLN
37
A
ILE
38
n
40
ILE
38
A
VAL
39
n
41
VAL
39
A
ALA
40
n
42
ALA
40
A
ARG
41
n
43
ARG
41
A
LEU
42
n
44
LEU
42
A
LYS
43
n
45
LYS
43
A
ASN
44
n
46
ASN
44
A
ASN
45
n
47
ASN
45
A
ASN
46
n
48
ASN
46
A
ARG
47
n
49
ARG
47
A
GLN
48
n
50
GLN
48
A
VAL
49
n
51
VAL
49
A
CYS
50
n
52
CYS
50
A
ILE
51
n
53
ILE
51
A
ASP
52
n
54
ASP
52
A
PRO
53
n
55
PRO
53
A
LYS
54
n
56
LYS
54
A
CYS
55
n
57
CYS
55
A
LYS
56
n
58
LYS
56
A
TRP
57
n
59
TRP
57
A
CYS
58
n
60
CYS
58
A
GLN
59
n
61
GLN
59
A
GLU
60
n
62
GLU
60
A
TYR
61
n
63
TYR
61
A
LEU
62
n
64
LEU
62
A
GLU
63
n
65
GLU
63
A
LYS
64
n
66
LYS
64
A
ALA
65
n
67
ALA
65
A
LEU
66
n
68
LEU
66
A
ASN
67
n
69
ASN
67
A
LYS
68
n
70
LYS
68
A
GLY
199
n
1
GLY
199
B
SER
200
n
2
SER
200
B
MET
201
n
3
MET
201
B
GLU
202
n
4
GLU
202
B
GLY
203
n
5
GLY
203
B
ILE
204
n
6
ILE
204
B
SER
205
n
7
SER
205
B
ILE
206
n
8
ILE
206
B
TYR
207
n
9
TYR
207
B
THR
208
n
10
THR
208
B
SER
209
n
11
SER
209
B
ASP
210
n
12
ASP
210
B
ASN
211
n
13
ASN
211
B
TYR
212
n
14
TYR
212
B
THR
213
n
15
THR
213
B
GLU
214
n
16
GLU
214
B
GLU
215
n
17
GLU
215
B
MET
216
n
18
MET
216
B
GLY
217
n
19
GLY
217
B
SER
218
n
20
SER
218
B
GLY
219
n
21
GLY
219
B
ASP
220
n
22
ASP
220
B
TYR
221
n
23
TYR
221
B
ASP
222
n
24
ASP
222
B
SER
223
n
25
SER
223
B
MET
224
n
26
MET
224
B
LYS
225
n
27
LYS
225
B
GLU
226
n
28
GLU
226
B
PRO
227
n
29
PRO
227
B
ALA
228
n
30
ALA
228
B
PHE
229
n
31
PHE
229
B
ARG
230
n
32
ARG
230
B
GLU
231
n
33
GLU
231
B
GLU
232
n
34
GLU
232
B
ASN
233
n
35
ASN
233
B
ALA
234
n
36
ALA
234
B
ASN
235
n
37
ASN
235
B
PHE
236
n
38
PHE
236
B
ASN
237
n
39
ASN
237
B
LYS
238
n
40
LYS
238
B
author_defined_assembly
2
dimeric
3281.2
-10.4
7408.4
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
VAL
49
A
O
VAL
51
A
N
ALA
40
A
N
ALA
42
A
O
GLN
37
A
O
GLN
39
A
N
LEU
29
A
N
LEU
31
A
N
ILE
28
A
N
ILE
30
B
O
SER
209
B
O
SER
11
4
A
B
HZ1
OE1
LYS
GLU
54
226
1.56
4
A
B
HG
O
SER
LYS
16
225
1.59
4
A
B
HZ3
OE2
LYS
GLU
56
231
1.59
6
A
B
HZ2
OE1
LYS
GLU
27
214
1.59
17
A
A
OD1
HZ2
ASP
LYS
52
54
1.58
1
A
SER
4
67.96
164.89
1
A
LEU
5
72.26
-32.80
1
A
ARG
8
-105.92
-80.78
1
A
CYS
34
-128.47
-89.45
1
A
LYS
43
-70.97
-70.59
1
B
MET
201
-148.59
-69.20
1
B
ILE
204
-130.71
-46.51
1
B
SER
205
65.52
91.02
1
B
ASN
211
-175.79
137.39
1
B
ALA
228
-128.54
-73.02
1
B
ARG
230
51.10
78.35
1
B
GLU
231
-169.57
-48.46
1
B
ASN
235
78.65
-22.72
2
A
SER
6
60.25
75.90
2
A
TYR
7
-143.01
25.70
2
A
ARG
8
79.96
-171.26
2
A
SER
16
-87.29
-72.57
2
A
ASN
30
-105.69
71.12
2
A
CYS
34
-142.71
-92.91
2
A
ASN
46
66.43
-4.82
2
B
LYS
225
-167.27
106.07
2
B
ALA
228
71.27
-77.92
2
B
PHE
229
-119.10
-73.84
2
B
ALA
234
65.86
-80.63
3
A
VAL
3
-71.92
-80.12
3
A
SER
4
70.93
116.98
3
A
ASN
30
-103.77
79.58
3
A
CYS
34
-149.34
-156.78
3
A
LYS
43
-68.91
-77.22
3
A
PRO
53
-66.79
19.19
3
B
MET
201
60.56
83.01
3
B
ILE
204
73.45
-49.67
3
B
SER
205
62.72
90.95
3
B
ASN
211
-175.16
147.33
3
B
LYS
225
73.92
110.77
3
B
ALA
228
-151.19
-54.97
3
B
PHE
229
-129.51
-67.04
3
B
ARG
230
173.18
-39.32
3
B
GLU
231
-140.86
-150.25
3
B
PHE
236
62.62
88.93
4
A
LEU
5
64.41
125.09
4
A
SER
6
61.55
97.74
4
A
ASN
30
-91.67
48.85
4
A
LYS
43
-71.29
-81.79
4
A
ASN
46
64.14
-6.09
4
B
SER
200
67.50
76.72
4
B
MET
201
-135.61
-65.97
4
B
GLU
202
-97.51
-62.37
4
B
ILE
206
-139.58
-154.50
4
B
SER
218
72.32
114.49
4
B
SER
223
-63.53
16.00
4
B
LYS
225
-177.85
103.51
4
B
ALA
228
173.77
-68.95
4
B
GLU
232
-90.51
-67.59
4
B
ALA
234
-59.73
97.99
5
A
ARG
8
-99.17
-72.95
5
A
CYS
34
-129.67
-98.06
5
A
LYS
43
-72.84
-72.19
5
B
ILE
206
-133.23
-159.57
5
B
ASN
211
175.39
158.14
5
B
TYR
212
-138.07
-154.28
5
B
THR
213
-140.69
16.82
5
B
ARG
230
71.18
-50.48
5
B
ASN
233
75.86
100.08
5
B
ASN
237
-87.40
-72.73
6
A
ARG
8
-66.38
-88.64
6
A
ARG
12
-100.75
-67.19
6
A
LYS
43
-70.52
-78.15
6
A
ASN
46
62.50
-3.35
6
A
CYS
55
-67.90
-176.49
6
B
GLU
202
-145.89
-37.89
6
B
SER
205
47.55
87.32
6
B
ILE
206
-125.75
-161.25
6
B
ASN
211
176.06
153.78
6
B
SER
218
165.07
-174.68
6
B
LYS
225
177.42
105.94
6
B
ALA
234
62.41
-165.72
7
A
LEU
29
-107.35
75.19
7
A
ALA
35
-94.31
-156.76
7
A
LYS
43
-69.72
-78.96
7
A
CYS
55
-58.94
171.21
7
B
SER
200
-166.78
-51.59
7
B
SER
205
64.99
87.07
7
B
TYR
212
-151.74
-84.23
7
B
THR
213
-162.58
-70.88
7
B
LYS
225
70.24
100.95
7
B
PHE
229
-153.14
-74.21
7
B
ARG
230
163.47
-37.94
8
A
VAL
3
65.81
95.87
8
A
ARG
8
65.32
-71.28
8
A
HIS
17
45.12
79.64
8
A
ASN
46
59.16
19.77
8
B
MET
201
69.63
92.32
8
B
ILE
204
-139.08
-51.83
8
B
SER
205
63.88
99.15
8
B
THR
213
-143.00
-32.81
8
B
MET
224
-87.00
-88.49
8
B
PRO
227
-62.22
-174.84
8
B
GLU
231
56.16
-39.36
8
B
GLU
232
-58.09
-71.38
8
B
ASN
235
-165.74
110.52
8
B
ASN
237
-155.30
83.74
9
A
ARG
8
69.53
174.01
9
A
LYS
43
-64.71
-89.12
9
B
ILE
204
-140.60
-45.67
9
B
SER
205
64.85
96.86
9
B
PRO
227
-84.28
-74.56
9
B
ALA
228
66.31
-72.26
9
B
PHE
229
-164.02
-52.82
9
B
ARG
230
73.53
72.12
9
B
GLU
231
-173.67
-148.38
9
B
GLU
232
-86.80
-79.18
9
B
ALA
234
58.61
4.95
9
B
PHE
236
-172.50
-39.05
9
B
ASN
237
72.45
84.36
10
A
SER
4
-98.56
48.28
10
A
TYR
7
-170.09
-58.50
10
A
ARG
8
176.68
-179.75
10
A
CYS
34
-131.85
-96.59
10
A
LYS
43
-70.46
-80.66
10
B
ILE
206
-119.13
-152.44
10
B
SER
223
27.94
-99.16
10
B
MET
224
-179.26
-168.63
10
B
PRO
227
-67.61
83.39
10
B
ALA
228
63.05
-73.30
10
B
PHE
229
-159.84
-15.48
10
B
ARG
230
68.38
-73.91
10
B
ASN
237
64.56
-177.35
11
A
SER
4
-147.93
36.75
11
A
ARG
8
-160.91
-165.47
11
A
CYS
34
-139.65
-96.67
11
A
LYS
43
-70.16
-75.85
11
A
ASN
46
48.47
81.42
11
B
ILE
206
-126.79
-154.65
11
B
ASN
211
173.72
162.39
11
B
SER
218
70.40
115.86
11
B
MET
224
-122.69
-160.93
11
B
PRO
227
-72.38
-158.73
11
B
PHE
229
-145.27
-38.30
11
B
ARG
230
69.77
-50.86
12
A
PRO
2
-76.92
24.50
12
A
SER
6
64.08
92.08
12
A
ARG
8
64.74
-89.10
12
A
ASN
30
-100.27
44.12
12
A
CYS
34
-124.31
-97.38
12
A
LYS
43
-69.17
-77.15
12
A
PRO
53
-69.61
8.89
12
B
SER
218
85.03
177.90
12
B
LYS
225
67.15
98.95
12
B
ARG
230
62.35
-82.56
13
A
MET
0
62.68
98.14
13
A
VAL
3
65.89
-84.22
13
A
SER
4
61.81
-176.25
13
A
ARG
12
-101.83
-60.93
13
A
CYS
34
-105.08
-94.54
13
A
CYS
55
-72.36
-166.10
13
B
ASN
211
165.13
167.54
13
B
SER
223
-58.75
43.28
13
B
LYS
225
78.03
76.40
13
B
ALA
234
64.56
-164.53
13
B
ASN
237
69.72
-79.01
14
A
PRO
2
-55.81
172.88
14
A
VAL
3
73.78
108.44
14
A
LEU
5
67.88
91.70
14
A
SER
6
-78.56
26.77
14
A
TYR
7
-172.69
-166.22
14
A
ASN
30
-104.15
79.79
14
A
LYS
43
-56.58
-78.15
14
A
ASN
46
58.99
15.27
14
A
PRO
53
-69.27
3.80
14
B
ILE
206
-133.34
-149.27
14
B
SER
218
-102.77
-69.53
14
B
LYS
225
-178.86
105.24
14
B
ALA
228
66.98
-54.69
14
B
ARG
230
-173.68
-71.74
14
B
GLU
231
-154.46
-61.36
14
B
ASN
233
171.57
-167.78
14
B
ASN
237
67.18
-63.57
15
A
PRO
2
-59.18
104.24
15
A
VAL
3
-148.34
-28.41
15
A
CYS
34
-103.88
-97.93
15
A
PRO
53
-63.87
7.38
15
B
SER
205
68.54
78.34
15
B
SER
218
-163.04
116.06
15
B
SER
223
73.34
66.96
15
B
LYS
225
-159.05
17.79
15
B
PHE
229
-136.72
-34.59
15
B
ARG
230
45.42
73.44
15
B
ASN
233
-147.13
-51.89
16
A
LYS
1
76.32
137.64
16
A
TYR
7
79.01
113.87
16
A
ARG
8
-132.16
-73.79
16
A
HIS
17
-154.27
88.37
16
A
CYS
34
-135.48
-93.75
16
A
PRO
53
-67.24
22.90
16
B
GLU
202
-172.97
-26.84
16
B
ILE
206
-129.42
-165.71
16
B
LYS
225
-170.25
90.31
16
B
ALA
228
168.60
15.63
16
B
PHE
229
-135.96
-75.99
16
B
ARG
230
-178.12
-43.19
16
B
GLU
231
-152.26
-44.13
16
B
ALA
234
-167.21
-19.82
17
A
SER
4
70.24
113.06
17
A
ARG
8
-118.00
-80.09
17
A
SER
16
-75.75
-72.52
17
A
CYS
34
-121.23
-93.02
17
A
LYS
43
-69.96
-76.78
17
B
THR
213
-144.11
13.04
17
B
LYS
225
-168.42
89.66
17
B
ALA
228
64.94
-81.78
17
B
PHE
229
-148.42
20.43
17
B
ARG
230
-57.43
105.26
17
B
GLU
231
-141.46
-76.41
17
B
GLU
232
-90.58
-64.05
17
B
PHE
236
68.62
-67.42
17
B
ASN
237
70.89
124.16
18
A
LEU
5
68.86
-89.58
18
A
ARG
8
176.31
161.57
18
A
HIS
17
49.59
75.07
18
A
LYS
43
-70.17
-79.32
18
B
MET
201
70.31
140.61
18
B
SER
205
69.34
-71.35
18
B
ILE
206
44.57
-146.21
18
B
THR
213
-139.64
-54.05
18
B
SER
218
-162.40
100.10
18
B
SER
223
-68.33
99.80
18
B
LYS
225
71.64
96.24
18
B
PHE
229
-151.49
-73.73
18
B
ARG
230
59.89
-82.69
18
B
ASN
233
73.39
-57.04
18
B
ALA
234
168.95
-53.23
18
B
ASN
235
176.04
133.00
18
B
ASN
237
73.41
112.44
19
A
LEU
5
-177.15
-68.29
19
A
TYR
7
-140.56
22.51
19
A
ARG
8
73.98
175.49
19
A
HIS
17
-152.80
85.37
19
A
CYS
34
-159.56
-157.36
19
A
LYS
43
-58.81
-89.58
19
A
ASN
46
62.25
88.64
19
A
PRO
53
-64.36
8.31
19
B
MET
201
59.08
81.79
19
B
ILE
206
-135.42
-155.96
19
B
TYR
221
-64.14
98.96
19
B
LYS
225
77.84
98.22
19
B
ALA
228
167.08
-70.45
19
B
ARG
230
70.84
-47.75
20
A
ARG
8
67.33
-168.06
20
A
CYS
34
-101.41
-94.63
20
A
LYS
43
-70.48
-79.82
20
A
LEU
66
-65.87
6.81
20
B
SER
200
69.24
99.98
20
B
SER
205
43.42
79.61
20
B
SER
218
65.38
113.59
20
B
SER
223
77.96
67.63
20
B
PHE
229
173.75
-28.08
20
B
ARG
230
69.62
-62.31
20
B
ALA
234
-138.39
-47.72
lowest energy, model1
Structure of constitutively monomeric CXCL12 in complex with the CXCR4 N-terminus
1
N
N
2
N
N
A
ALA
19
A
ALA
21
HELX_P
A
ALA
21
A
ALA
23
5
1
3
A
LYS
56
A
LYS
58
HELX_P
A
LEU
66
A
LEU
68
1
2
11
disulf
2.027
A
CYS
9
A
SG
CYS
11
1_555
A
CYS
34
A
SG
CYS
36
1_555
disulf
2.015
A
CYS
11
A
SG
CYS
13
1_555
A
CYS
50
A
SG
CYS
52
1_555
disulf
2.028
A
CYS
55
A
SG
CYS
57
1_555
A
CYS
58
A
SG
CYS
60
1_555
CYTOKINE/Signaling Protein
CXL12, CXCR4, chemokine, GPCR, SDF1, CYTOKINE-Signaling Protein complex
SDF1_HUMAN
UNP
1
22
P48061
KPVSLSYRCPCRFFESHVARANVKHLKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALNK
CXCR4_HUMAN
UNP
2
1
P61073
MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNK
22
89
2N55
1
68
P48061
A
1
3
70
1
38
2N55
201
238
P61073
B
2
3
40
1
expression tag
GLY
-1
2N55
A
P48061
UNP
1
1
expression tag
MET
0
2N55
A
P48061
UNP
2
1
LEU
engineered mutation
CYS
55
2N55
A
P48061
UNP
76
57
1
ILE
engineered mutation
CYS
58
2N55
A
P48061
UNP
79
60
2
expression tag
GLY
199
2N55
B
P61073
UNP
1
2
expression tag
SER
200
2N55
B
P61073
UNP
2
2
CYS
engineered mutation
ALA
228
2N55
B
P61073
UNP
28
30
4
anti-parallel
anti-parallel
parallel
A
GLN
48
A
GLN
50
A
ILE
51
A
ILE
53
A
LEU
36
A
LEU
38
A
LEU
42
A
LEU
44
A
VAL
23
A
VAL
25
A
ASN
30
A
ASN
32
B
THR
208
B
THR
10
B
SER
209
B
SER
11